| CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed) | National Institutes of Health | $300,000 | Oct 16, 2026 |
| Strengthening Ghana Health Service laboratory services, diagnostic networks, and systems for a more effective, efficient, and sustainable response to HIV, TB, and other priority health threats | Centers for Disease Control-GHC | Not specified | Oct 16, 2026 |
| Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional) | National Institutes of Health | $50,000 | Oct 19, 2026 |
| Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Oct 19, 2026 |
| Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | National Institutes of Health | $600,000 | Oct 19, 2026 |
| PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional) | National Institutes of Health | Not specified | Oct 19, 2026 |
| Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional) | National Institutes of Health | Not specified | Oct 19, 2026 |
| Fiscal Year (FY) 2027 Service Area Competition (SAC) | Health Resources and Services Administration | $10,116,100 | Oct 19, 2026 |
| Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | National Institutes of Health | $600,000 | Oct 19, 2026 |
| Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional) | National Institutes of Health | $750,000 | Oct 20, 2026 |
| Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required) | National Institutes of Health | Not specified | Oct 22, 2026 |
| GREGoRi Technology Integration Center (U01, Clinical Trials Optional) | National Institutes of Health | $2,250,000 | Oct 30, 2026 |
| GREGoRi Innovation Projects (U01 Clinical Trial Optional) | National Institutes of Health | $500,000 | Oct 30, 2026 |
| GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed) | National Institutes of Health | $1,250,000 | Oct 30, 2026 |
| HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required) | National Institutes of Health | Not specified | Oct 30, 2026 |
| Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Nov 2, 2026 |
| Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) | National Institutes of Health | Not specified | Nov 2, 2026 |
| Exploring and Enhancing Outdoor and Heritage Tourism in the Chesapeake Bay Watershed | National Park Service | $50,000 | Nov 4, 2026 |
| Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Nov 5, 2026 |
| Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases | Centers for Disease Control and Prevention - ERA | $6,000,000 | Nov 5, 2026 |
| US Travelers Health Research, Surveillance, Communication, and Outreach Network | Centers for Disease Control and Prevention - ERA | $1,000,000 | Nov 5, 2026 |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) | National Institutes of Health | $350,000 | Nov 6, 2026 |
| Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) | National Institutes of Health | Not specified | Nov 10, 2026 |
| Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | National Institutes of Health | $300,000 | Nov 10, 2026 |
| Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) | National Institutes of Health | $150,000 | Nov 10, 2026 |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | National Institutes of Health | Not specified | Nov 10, 2026 |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | National Institutes of Health | Not specified | Nov 10, 2026 |
| Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Nov 10, 2026 |
| Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed) | National Institutes of Health | $100,000 | Nov 10, 2026 |
| NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) | National Institutes of Health | Not specified | Nov 13, 2026 |
| NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) | National Institutes of Health | $350,000 | Nov 13, 2026 |
| NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) | National Institutes of Health | $750,000 | Nov 13, 2026 |
| NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) | National Institutes of Health | $1,050,000 | Nov 13, 2026 |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | National Institutes of Health | $50,000 | Nov 16, 2026 |
| NIJ FY 2026 Research and Evaluation on Human Trafficking | National Institute of Justice | $2,500,000 | Nov 16, 2026 |
| NIJ FY 2026 Crime and Justice Research | National Institute of Justice | $5,000,000 | Nov 16, 2026 |
| Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required) | National Institutes of Health | Not specified | Nov 17, 2026 |
| Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required) | National Institutes of Health | Not specified | Nov 17, 2026 |
| NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required) | National Institutes of Health | $350,000 | Nov 17, 2026 |
| Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) | National Institutes of Health | Not specified | Nov 17, 2026 |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) | National Institutes of Health | $200,000 | Nov 17, 2026 |
| Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required) | National Institutes of Health | Not specified | Nov 17, 2026 |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | National Institutes of Health | Not specified | Nov 18, 2026 |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | National Institutes of Health | Not specified | Nov 18, 2026 |
| NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional) | National Institutes of Health | Not specified | Nov 19, 2026 |
| Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) | National Institutes of Health | Not specified | Nov 19, 2026 |
| NIJ FY 2026 Research and Evaluation on School Safety | National Institute of Justice | $5,000,000 | Nov 23, 2026 |
| Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Nov 23, 2026 |
| Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed) | National Institutes of Health | Not specified | Nov 23, 2026 |
| Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed) | National Institutes of Health | Not specified | Nov 23, 2026 |
| Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) | National Institutes of Health | Not specified | Nov 24, 2026 |
| National Center for Construction Safety and Health Research and Translation (U54) | Centers for Disease Control and Prevention - ERA | $5,750,000 | Dec 1, 2026 |
| Accelerating Scale-up and Pre-piloting of Emerging Chemical Technologies (ASPECT) | Golden Field Office | $20,000,000 | Dec 1, 2026 |
| Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) | National Institutes of Health | Not specified | Dec 2, 2026 |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | National Institutes of Health | Not specified | Dec 4, 2026 |
| Cooperative Research Agreements Related to the World Trade Center Health Program (U01) | Centers for Disease Control and Prevention - ERA | $550,000 | Dec 8, 2026 |
| Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21) | Centers for Disease Control and Prevention - ERA | $365,000 | Dec 8, 2026 |
| Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed) | National Institutes of Health | $800,000 | Dec 14, 2026 |
| Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed) | National Institutes of Health | $2,000,000 | Dec 14, 2026 |
| Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed) | National Institutes of Health | $1,500,000 | Dec 14, 2026 |
| IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed) | National Institutes of Health | $4,000,000 | Dec 14, 2026 |
| Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) | National Institutes of Health | Not specified | Jan 7, 2027 |
| Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) | National Institutes of Health | Not specified | Jan 7, 2027 |
| Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) | National Institutes of Health | Not specified | Jan 7, 2027 |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | National Institutes of Health | Not specified | Jan 7, 2027 |
| Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 7, 2027 |
| Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) | National Institutes of Health | Not specified | Jan 7, 2027 |
| Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) | National Institutes of Health | Not specified | Jan 7, 2027 |
| Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional) | National Institutes of Health | Not specified | Jan 7, 2027 |
| Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) | National Institutes of Health | Not specified | Jan 7, 2027 |
| National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) | National Institutes of Health | $499,999 | Jan 7, 2027 |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) | National Institutes of Health | $1,515,000 | Jan 7, 2027 |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) | National Institutes of Health | Not specified | Jan 7, 2027 |
| Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 7, 2027 |
| NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional) | National Institutes of Health | Not specified | Jan 7, 2027 |
| Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) | National Institutes of Health | $500,000 | Jan 7, 2027 |
| Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) | National Institutes of Health | $250,000 | Jan 7, 2027 |
| Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 11, 2027 |
| Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required) | National Institutes of Health | $700,000 | Jan 11, 2027 |
| Title X Family Planning Services Grants | Office of the Assistant Secretary for Health | $22,000,000 | Jan 11, 2027 |
| HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) | National Institutes of Health | $350,000 | Jan 15, 2027 |
| ROSS Rapid Response Program | Department of Housing and Urban Development | $250,000 | Jan 25, 2027 |
| Medical Scientist Training Program (MSTP) (T32) | National Institutes of Health | Not specified | Jan 25, 2027 |
| National Centers for Cryo-electron Tomography (cryoET) (R24 -Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 26, 2027 |
| HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR) - Building Engagement, Assistance, Capacity, Outreach, and Networks (BEACON) Center (U2C Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 26, 2027 |
| HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers (RM1 Clinical Trial Required) | National Institutes of Health | Not specified | Jan 26, 2027 |
| Diabetes Research Centers (P30 Clinical Trial Optional) | National Institutes of Health | $1,000,000 | Jan 27, 2027 |
| Translational Neural Devices (R61/R33 - Clinical Trial Optional) | National Institutes of Health | Not specified | Jan 28, 2027 |
| BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed) | National Institutes of Health | $750,000 | Jan 28, 2027 |
| Minor Use Minor Species Development of Drugs (R01) | Food and Drug Administration | $250,000 | Jan 29, 2027 |
| BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Feb 8, 2027 |
| Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Feb 8, 2027 |
| Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed) | National Institutes of Health | $700,000 | Feb 9, 2027 |
| Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional) | National Institutes of Health | $750,000 | Feb 10, 2027 |
| NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Feb 11, 2027 |
| BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed) | National Institutes of Health | $700,000 | Feb 11, 2027 |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Feb 11, 2027 |
| Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional) | National Institutes of Health | Not specified | Feb 26, 2027 |
| Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Mar 1, 2027 |
| NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) | National Institutes of Health | Not specified | Mar 4, 2027 |
| High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional) | National Institutes of Health | $1,500,000 | Mar 5, 2027 |
| Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Mar 5, 2027 |
| Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional) | National Institutes of Health | $500,000 | Mar 6, 2027 |
| High Priority HIV and Substance Use Research (R01 Clinical Trial Optional) | National Institutes of Health | Not specified | Mar 6, 2027 |
| Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional) | National Institutes of Health | Not specified | Mar 6, 2027 |
| Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed) | National Institutes of Health | $500,000 | Mar 10, 2027 |
| Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required) | National Institutes of Health | Not specified | Mar 16, 2027 |
| Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed) | National Institutes of Health | $200,000 | Apr 9, 2027 |
| Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed) | National Institutes of Health | $250,000 | Apr 15, 2027 |
| Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) | National Institutes of Health | Not specified | Apr 18, 2027 |
| Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional) | National Institutes of Health | Not specified | Apr 20, 2027 |
| NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) | National Institutes of Health | Not specified | Apr 28, 2027 |
| NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) | National Institutes of Health | Not specified | Apr 28, 2027 |
| Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required) | National Institutes of Health | Not specified | May 7, 2027 |
| Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed) | National Institutes of Health | Not specified | May 7, 2027 |
| NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) | National Institutes of Health | Not specified | May 7, 2027 |
| New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) | National Institutes of Health | Not specified | May 7, 2027 |
| New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) | National Institutes of Health | Not specified | May 7, 2027 |
| Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional) | National Institutes of Health | Not specified | May 7, 2027 |
| Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required) | National Institutes of Health | Not specified | May 7, 2027 |
| NIDCD Research Career Enhancement Award for Established Investigators (K18 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | May 7, 2027 |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | National Institutes of Health | Not specified | May 7, 2027 |
| NIDCD Research Career Enhancement Award for Established Investigators (K18 Clinical Trial Required) | National Institutes of Health | Not specified | May 7, 2027 |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | National Institutes of Health | Not specified | May 7, 2027 |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed) | National Institutes of Health | Not specified | May 7, 2027 |
| NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Clinical Trial Required) | National Institutes of Health | Not specified | May 7, 2027 |
| Independent Scientist Award (Parent K02 - Independent Clinical Trial Required) | National Institutes of Health | Not specified | May 7, 2027 |
| NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Independent Clinical Trial Not Allowed) | National Institutes of Health | Not specified | May 7, 2027 |
| Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed) | National Institutes of Health | Not specified | May 7, 2027 |
| NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) | National Institutes of Health | Not specified | May 7, 2027 |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) | National Institutes of Health | Not specified | May 7, 2027 |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | National Institutes of Health | Not specified | May 7, 2027 |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) | National Institutes of Health | Not specified | May 8, 2027 |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required) | National Institutes of Health | Not specified | May 8, 2027 |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required) | National Institutes of Health | Not specified | May 8, 2027 |
| Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed) | National Institutes of Health | $500,000 | May 25, 2027 |
| NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed) | National Institutes of Health | $200,000 | May 26, 2027 |
| NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed) | National Institutes of Health | $400,000 | May 26, 2027 |
| Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed) | National Institutes of Health | $3,500,000 | May 28, 2027 |
| Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional) | National Institutes of Health | Not specified | Jun 2, 2027 |
| Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional) | National Institutes of Health | Not specified | Jun 2, 2027 |
| NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jun 14, 2027 |
| BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional) | National Institutes of Health | Not specified | Jun 15, 2027 |
| BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jun 15, 2027 |
| Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional) | National Institutes of Health | Not specified | Jun 17, 2027 |
| Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jul 2, 2027 |
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | National Institutes of Health | Not specified | Jul 12, 2027 |
| NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required) | National Institutes of Health | Not specified | Jul 12, 2027 |
| NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jul 12, 2027 |
| Successor-in-Interest (Type 6 Parent Clinical Trial Optional) | National Institutes of Health | Not specified | Jul 17, 2027 |
| Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) | National Institutes of Health | $150,000 | Aug 11, 2027 |
| Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) | National Institutes of Health | Not specified | Aug 18, 2027 |
| Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Sep 7, 2027 |
| Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Sep 7, 2027 |
| Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) | National Institutes of Health | Not specified | Sep 7, 2027 |
| Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) | National Institutes of Health | Not specified | Sep 7, 2027 |
| NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Sep 7, 2027 |
| Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Sep 10, 2027 |
| NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Sep 25, 2027 |
| Clinical and Translational Science Award (UM1 Clinical Trial Optional) | National Institutes of Health | Not specified | Sep 28, 2027 |
| Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed) | National Institutes of Health | $250,000 | Sep 29, 2027 |
| Home Study and Post-Release Services for Unaccompanied Alien Children​​ | Administration for Children and Families - ORR | $100,000,000 | Oct 1, 2027 |
| BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Oct 4, 2027 |
| Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Oct 8, 2027 |
| Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional) | National Institutes of Health | Not specified | Oct 8, 2027 |
| NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional) | National Institutes of Health | $500,000 | Oct 12, 2027 |
| NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Oct 14, 2027 |
| NCI Pathway to Independence Award (K99/R00 Clinical Trial Required) | National Institutes of Health | Not specified | Oct 14, 2027 |
| Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required) | National Institutes of Health | Not specified | Oct 15, 2027 |
| Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required) | National Institutes of Health | Not specified | Oct 15, 2027 |
| Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required) | National Institutes of Health | Not specified | Oct 15, 2027 |
| Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required) | National Institutes of Health | Not specified | Oct 15, 2027 |
| Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required) | National Institutes of Health | Not specified | Oct 15, 2027 |
| Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) | National Institutes of Health | Not specified | Oct 15, 2027 |
| Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required) | National Institutes of Health | Not specified | Oct 15, 2027 |
| First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required) | National Institutes of Health | Not specified | Oct 15, 2027 |
| Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required) | National Institutes of Health | Not specified | Oct 15, 2027 |
| NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional) | National Institutes of Health | Not specified | Oct 15, 2027 |
| NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Oct 16, 2027 |
| NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required) | National Institutes of Health | Not specified | Oct 18, 2027 |
| Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) | National Institutes of Health | $300,000 | Oct 19, 2027 |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Oct 20, 2027 |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) | National Institutes of Health | $750,000 | Oct 20, 2027 |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) | National Institutes of Health | $750,000 | Oct 20, 2027 |
| Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) | National Institutes of Health | Not specified | Oct 25, 2027 |
| Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) | National Institutes of Health | Not specified | Oct 25, 2027 |
| National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional) | National Institutes of Health | Not specified | Oct 25, 2027 |
| National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional) | National Institutes of Health | Not specified | Oct 25, 2027 |
| Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Oct 28, 2027 |
| Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required) | National Institutes of Health | Not specified | Nov 5, 2027 |
| Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) | National Institutes of Health | $1,500,000 | Nov 5, 2027 |
| Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional) | National Institutes of Health | Not specified | Nov 5, 2027 |
| BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Nov 8, 2027 |
| NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Nov 12, 2027 |
| Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required) | National Institutes of Health | Not specified | Nov 12, 2027 |
| Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Nov 12, 2027 |
| Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) | National Institutes of Health | $6,250,000 | Nov 15, 2027 |
| Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Nov 15, 2027 |
| Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional) | National Institutes of Health | Not specified | Nov 16, 2027 |
| Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed) | National Institutes of Health | $100,000 | Nov 16, 2027 |
| Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional) | National Institutes of Health | $200,000 | Nov 16, 2027 |
| Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Nov 16, 2027 |
| Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Nov 16, 2027 |
| Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) | National Institutes of Health | $300,000 | Nov 18, 2027 |
| Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Dec 3, 2027 |
| Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Dec 3, 2027 |
| Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Dec 23, 2027 |
| Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Dec 23, 2027 |
| Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) | National Institutes of Health | $350,000 | Dec 23, 2027 |
| Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Dec 23, 2027 |
| Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) | National Institutes of Health | Not specified | Dec 23, 2027 |
| NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) | National Institutes of Health | $500,000 | Jan 6, 2028 |
| NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) | National Institutes of Health | Not specified | Jan 6, 2028 |
| Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 6, 2028 |
| Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required) | National Institutes of Health | Not specified | Jan 6, 2028 |
| Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Focused Technology Research and Development (R01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Laboratories to Optimize Digital Health (R01 Clinical Trial Required) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed) | National Institutes of Health | $200,000 | Jan 7, 2028 |
| NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) | National Institutes of Health | $500,000 | Jan 7, 2028 |
| Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) | National Institutes of Health | $500,000 | Jan 7, 2028 |
| NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) | National Institutes of Health | $150,000 | Jan 7, 2028 |
| Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) | National Institutes of Health | Not specified | Jan 7, 2028 |
| NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 7, 2028 |
| NICHD Small Research Grant Program (R03 Clinical Trial Required) | National Institutes of Health | $50,000 | Jan 7, 2028 |
| Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) | National Institutes of Health | $500,000 | Jan 7, 2028 |
| Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) | National Institutes of Health | $200,000 | Jan 7, 2028 |
| Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R34 Clinical Trial Required) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R01 Clinical Trial Required) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 7, 2028 |
| NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) | National Institutes of Health | $50,000 | Jan 7, 2028 |
| Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) | National Institutes of Health | $75,000 | Jan 7, 2028 |
| Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) | National Institutes of Health | $499,000 | Jan 7, 2028 |
| Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) | National Institutes of Health | Not specified | Jan 7, 2028 |
| NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32) | National Institutes of Health | Not specified | Jan 7, 2028 |
| NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed) | National Institutes of Health | $150,000 | Jan 7, 2028 |
| Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) | National Institutes of Health | Not specified | Jan 7, 2028 |
| NIH Research Project Grant (Parent R01 Clinical Trial Required) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) | National Institutes of Health | $225,000 | Jan 7, 2028 |
| Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) | National Institutes of Health | $499,000 | Jan 7, 2028 |
| The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional) | National Institutes of Health | Not specified | Jan 7, 2028 |
| NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) | National Institutes of Health | Not specified | Jan 7, 2028 |
| NCMRR Early Career Research Award (R03 Clinical Trial Optional) | National Institutes of Health | $200,000 | Jan 7, 2028 |
| NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 7, 2028 |
| NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 7, 2028 |
| Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 10, 2028 |
| Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) | National Institutes of Health | Not specified | Jan 28, 2028 |
| Commercial Fishing Occupational Safety Training Project Grants (T03) | Centers for Disease Control and Prevention - ERA | $975,000 | Jan 31, 2028 |
| Commercial Fishing Occupational Safety Research Cooperative Agreement (U01) | Centers for Disease Control and Prevention - ERA | $975,000 | Jan 31, 2028 |
| Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Feb 17, 2028 |
| Environmental influences on Child Health Outcomes (ECHO) Cohort Data and Biospecimen Access (X01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Mar 1, 2028 |
| Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) | National Institutes of Health | Not specified | May 4, 2028 |
| NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | May 7, 2028 |
| Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35) | National Institutes of Health | Not specified | May 7, 2028 |
| Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) | National Institutes of Health | $1,000,000 | May 7, 2028 |
| Community-Partnered Nursing Research Centers (P20 Clinical Trial Optional) | National Institutes of Health | $500,000 | May 7, 2028 |
| NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed) | National Institutes of Health | Not specified | May 8, 2028 |
| Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional) | National Institutes of Health | Not specified | May 25, 2028 |
| Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed) | National Institutes of Health | $2,100,000 | May 26, 2028 |
| Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional) | National Institutes of Health | Not specified | May 26, 2028 |
| Mind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechanisms (R61/R33 Clinical Trial Required) | National Institutes of Health | Not specified | Jun 7, 2028 |
| Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jun 12, 2028 |
| INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed) | National Institutes of Health | $500,000 | Jun 15, 2028 |
| INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required) | National Institutes of Health | Not specified | Jun 15, 2028 |
| INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed) | National Institutes of Health | $200,000 | Jun 15, 2028 |
| Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) | National Institutes of Health | Not specified | Jun 16, 2028 |
| BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed) | National Institutes of Health | $8,000,000 | Jun 23, 2028 |
| Seed Instrumentation Support (SIS) Program (S10 Clinical Trial Not Allowed) | National Institutes of Health | $400,000 | Jul 1, 2028 |
| Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) | National Institutes of Health | $5,000,000 | Jul 1, 2028 |
| Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional) | National Institutes of Health | $499,000 | Jul 7, 2028 |
| Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) | National Institutes of Health | $125,000 | Jul 16, 2028 |
| Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jul 20, 2028 |
| Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) | National Institutes of Health | $3,000,000 | Aug 21, 2028 |
| Transformative Non-Invasive/Minimally Invasive Technologies for Imaging the Olfactory System Across Scales (R01 CT Optional) | National Institutes of Health | $500,000 | Aug 21, 2028 |
| Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Aug 25, 2028 |
| Vet-LIRN Capacity-Building Project and Equipment Grants (U18) | Food and Drug Administration | $2,500,000 | Sep 4, 2028 |
| Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) | National Institutes of Health | Not specified | Sep 7, 2028 |
| Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional) | National Institutes of Health | Not specified | Sep 7, 2028 |
| Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) | National Institutes of Health | Not specified | Sep 25, 2028 |
| Limited Competition: NIGMS Mature Synchrotron Resources (MSR) for Structural Biology (P30 - Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Oct 2, 2028 |
| BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Oct 6, 2028 |
| Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Oct 9, 2028 |
| Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed) | National Institutes of Health | $200,000 | Oct 20, 2028 |
| Occupational Safety and Health Education and Research Centers (T42) | Centers for Disease Control and Prevention - ERA | $9,000,000 | Oct 26, 2028 |
| Occupational Safety and Health Training Project Grants (T03) | Centers for Disease Control and Prevention - ERA | $550,000 | Oct 26, 2028 |
| Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) | National Institutes of Health | Not specified | Nov 2, 2028 |
| Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) | National Institutes of Health | Not specified | Nov 2, 2028 |
| Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) | National Institutes of Health | Not specified | Nov 2, 2028 |
| Early Immune System Development and Ontogeny (R01 Clinical Trial Optional) | National Institutes of Health | $400,000 | Nov 5, 2028 |
| CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed) | National Institutes of Health | $300,000 | Nov 5, 2028 |
| Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) | National Institutes of Health | $85,000 | Nov 7, 2028 |
| Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional) | National Institutes of Health | $300,000 | Nov 16, 2028 |
| The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) | National Institutes of Health | $500,000 | Nov 22, 2028 |
| Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) | National Institutes of Health | Not specified | Nov 30, 2028 |
| Limited Competition: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed) | National Institutes of Health | $250,000 | Jan 26, 2029 |
| Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jan 29, 2029 |
| Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI) | National Institutes of Health | Not specified | Feb 6, 2029 |
| BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Feb 8, 2029 |
| HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional) | National Institutes of Health | Not specified | Feb 9, 2029 |
| HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) | National Institutes of Health | Not specified | Feb 20, 2029 |
| NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed) | National Institutes of Health | $500,000 | Mar 1, 2029 |
| Research Grants in Clinical Informatics (R01 Clinical Trial Optional) | National Institutes of Health | $250,000 | Mar 5, 2029 |
| Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional) | National Institutes of Health | $250,000 | Mar 5, 2029 |
| NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required) | National Institutes of Health | Not specified | Mar 9, 2029 |
| Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Mar 12, 2029 |
| Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional) | National Institutes of Health | Not specified | Mar 16, 2029 |
| SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) | National Institutes of Health | Not specified | Apr 5, 2029 |
| NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Apr 17, 2029 |
| NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed) | National Institutes of Health | Not specified | May 5, 2029 |
| NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed) | National Institutes of Health | Not specified | May 5, 2029 |
| NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) | National Institutes of Health | Not specified | May 7, 2029 |
| Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | May 7, 2029 |
| NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | May 25, 2029 |
| NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | May 25, 2029 |
| NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) | National Institutes of Health | Not specified | May 25, 2029 |
| NIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed) | National Institutes of Health | Not specified | May 25, 2029 |
| Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed) | National Institutes of Health | Not specified | May 25, 2029 |
| NIH Research Program Projects (Parent P01 Clinical Trial Optional) | National Institutes of Health | Not specified | May 25, 2029 |
| Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional) | National Institutes of Health | Not specified | May 30, 2029 |
| Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) | National Institutes of Health | Not specified | Jun 20, 2029 |
| Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jul 5, 2029 |
| Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed) | National Institutes of Health | $500,000 | Jul 5, 2029 |
| NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) | National Institutes of Health | Not specified | Jul 5, 2029 |
| NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed) | National Institutes of Health | $500,000 | Jul 5, 2029 |
| Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) | National Institutes of Health | $500,000 | Jul 5, 2029 |
| Academic Career Excellence (ACE) Award (K32 Independent Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Jul 12, 2029 |
| Limited Competition: Small Grant Program for Mentored Research Career Development Award Recipients (R03) (Clinical Trials Not Allowed) | National Institutes of Health | Not specified | Jul 16, 2029 |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required) | National Institutes of Health | Not specified | Sep 25, 2029 |
| Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional) | National Institutes of Health | Not specified | Sep 26, 2029 |
| Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional) | National Institutes of Health | Not specified | Oct 11, 2029 |
| Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional) | National Institutes of Health | $600,000 | Nov 5, 2029 |
| Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional) | National Institutes of Health | Not specified | Nov 5, 2029 |
| NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Nov 16, 2029 |
| Making America Healthy Again by Addressing Dementia Disparities | Office of the Assistant Secretary for Health | $600,000 | Forecast |
| Coordinating Center for Language Access Services | Office of the Assistant Secretary for Health | $700,000 | Forecast |
| Promoting Access with a Language Services Assistance Symbol | Office of the Assistant Secretary for Health | $600,000 | Forecast |
| National Training Center for Title X and Teen Pregnancy Prevention (TPP) | Office of the Assistant Secretary for Health | $1,500,000 | Forecast |
| National Training Center for Title X and Teen Pregnancy Prevention (TPP) | Office of the Assistant Secretary for Health | $3,500,000 | Forecast |
| Pregnancy and Postpartum Hypertension Control Initiative | Office of the Assistant Secretary for Health | $550,000 | Forecast |
| Notice of Intent to Publish a Funding Opportunity Announcement for Morris K. Udall Discovery Centers without Walls (DCWoW) for Parkinson's Disease Research (RM1 - Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Forecast to Renew the Funding Opportunity Announcement for Multiple Chronic Disease Research Centers Coordinating Center (U24 Clinical Trial Not Required) | National Institutes of Health | Not specified | Forecast |
| Forecast for NINDS Exploratory Grant Program in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Research (P20 - Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Forecast for NIH Blueprint and BRAIN Initiative ACTION Potential Program (F99/K00 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Small Business Translator: MedTech and Digital Health Technologies | National Institutes of Health | Not specified | Forecast |
| NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Forecast to Publish a Funding Opportunity Announcement for Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care | National Institutes of Health | Not specified | Forecast |
| Pilot Effectiveness Trials of Peer Support Services for Suicide Prevention | National Institutes of Health | Not specified | Forecast |
| Resource and Capacity Building to Advance the Science of Aggression across Species and Disciplines (R24 Clinical Trial Optional) | National Institutes of Health | $6 | Forecast |
| Forecast to Publish a Funding Opportunity Announcement for EmbraceHealth Clinical Research Network to Reduce Health Disparities – Coordinating Center | National Institutes of Health | Not specified | Forecast |
| Notice of Intent to Publish a Forecast for EmbraceHealth Clinical Research Network to Reduce Health Disparities – Research Sites | National Institutes of Health | Not specified | Forecast |
| Extracellular Vesicle Therapeutics for Regenerative Medicine (ExTReMe) | National Institutes of Health | Not specified | Forecast |
| Dementia Care and Caregiver Support Intervention Research - Stages II - V | National Institutes of Health | Not specified | Forecast |
| Dementia Care and Caregiver Support Intervention Research - Stage I Only | National Institutes of Health | Not specified | Forecast |
| Forecast to Publish a Notice of Funding Opportunity for Academic Career Excellence (ACE) Award (K32 - Clinical Trial Required) | National Institutes of Health | Not specified | Forecast |
| Continued Development of the Gabriella Miller Kids First Pediatric Data Resource Center (U2C Clinical Trials Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Gabriella Miller Kids First Training and Outreach Core (U24 Clinical Trials Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Forecast to Publish a Funding Opportunity Announcement for Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Research Project Sites (U01 Clinical Trials Optional) | National Institutes of Health | Not specified | Forecast |
| Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Infrastructure for Population Dynamics Research Program (iPOP) | National Institutes of Health | Not specified | Forecast |
| Forecast to Publish a Funding Opportunity Announcement for the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Research Resource (Collaborative U24 - Clinical Trials not allowed) | National Institutes of Health | Not specified | Forecast |
| Forecast to Publish a Funding Opportunity Announcement for the Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Administrative Resource (Collaborative U24 - Clinical Trials not allowed) | National Institutes of Health | Not specified | Forecast |
| Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24 Clinical Trials Optional) | National Institutes of Health | Not specified | Forecast |
| Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24 Clinical Trials Optional) | National Institutes of Health | Not specified | Forecast |
| Notice of Intent to Publish a Funding Opportunity Announcement for Trailblazer Award for New and Early-Stage Investigators (R21 Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Martin Delaney Collaboratories for HIV Cure Research | National Institutes of Health | Not specified | Forecast |
| Forecast to Publish a Notice of Funding Opportunity for Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Forecast to Publish a Funding Opportunity Announcement for Copy of Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24) (Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Forecast to Publish a Funding Opportunity Announcement for Copy of Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource Core (U24) (Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Forecast to Publish a Funding Opportunity Announcement for Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia (U01 Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Forecast to Renew the Notice of Funding Opportunity Announcement for the Multiple Chronic Disease Research Centers | National Institutes of Health | Not specified | Forecast |
| Notice of Intent to Publish a Funding Opportunity Announcement for Single Source for Continuation of the Environmental Determinants of Diabetes in The Young Study (TEDDY) Data Coordinating Center (U01 Clinical Trial Not Allowed) | National Institutes of Health | $6,000,000 | Forecast |
| Limited Competition: Community-Partnered Nursing Research Centers for Schools and Colleges of Nursing with Limited NIH Funding (P20 Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Notice of Intent to Publish a Funding Opportunity Announcement for Impact of Technology and Digital Media Exposure Usage on Child and Adolescent Development | National Institutes of Health | Not specified | Forecast |
| Notice of Intent to Publish a Funding Opportunity Announcement for ClinGen Genomic Curation Expert Panels | National Institutes of Health | Not specified | Forecast |
| Notice of Intent to Publish a Funding Opportunity Announcement for HIV Pediatric, Adolescent and Maternal Clinical Trials | National Institutes of Health | Not specified | Forecast |
| Selective Precision Targeting (SPoT) | National Institutes of Health | Not specified | Forecast |
| Biomarkers of Cognitive Decline and Dementias of Aging in Individuals within the Autism Spectrum | National Institutes of Health | Not specified | Forecast |
| Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline | National Institutes of Health | Not specified | Forecast |
| Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials | National Institutes of Health | Not specified | Forecast |
| Infertility Training Center | Office of the Assistant Secretary for Health | $1,500,000 | Forecast |
| Funding Opportunity Announcement for Impact of Environmental Exposures on Gut-Brain Signaling in Neurological Conditions (R01) | National Institutes of Health | Not specified | Forecast |
| Forecast to Publish a Notice of Funding Opportunity for Paul Calabresi Career Development Award in Clinical Oncology (K12 Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| ancient DNA for Modern Genomics (aDMG) Data Generation and Resource Center | National Institutes of Health | Not specified | Forecast |
| ancient DNA for Modern Genomics (aDMG) Coordination Center | National Institutes of Health | Not specified | Forecast |
| Centers for Genomics Research Capacity Building | National Institutes of Health | Not specified | Forecast |
| Clinical Data Ecosystem for Genomics (CDEG) | National Institutes of Health | Not specified | Forecast |
| Data Standards for Tobacco Research and Scientific Review Phase 2 | Food and Drug Administration | Not specified | Forecast |
| FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed) | Food and Drug Administration | Not specified | Forecast |
| Center for Research on Complex Generics (U18) Clinical Trials Optional | Food and Drug Administration | $1,500,000 | Forecast |
| NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens | Food and Drug Administration | $4,500,000 | Forecast |
| REACHing Communities (REACH) Consortium (U01) Clinical Trials Optional | Food and Drug Administration | $3,000,000 | Forecast |
| Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed | Food and Drug Administration | $300,000 | Forecast |
| FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed | Food and Drug Administration | $1,000,000 | Forecast |
| Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional | Food and Drug Administration | $500,000 | Forecast |
| Minor Use Minor Species Development of Drugs (R01) | Food and Drug Administration | $250,000 | Forecast |
| Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required) | Food and Drug Administration | $250,000 | Forecast |
| Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) Clinical Trial Not Allowed | Food and Drug Administration | $200,000 | Forecast |
| Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics | Food and Drug Administration | Not specified | Forecast |
| Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed | Food and Drug Administration | $250,000 | Forecast |
| OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed | Food and Drug Administration | $250,000 | Forecast |
| Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01) | Food and Drug Administration | $350,000 | Forecast |
| Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical Trials Not Allowed | Food and Drug Administration | Not specified | Forecast |
| Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed | Food and Drug Administration | $2,000,000 | Forecast |
| Innovative Approaches for Reducing Disparities in Kidney Health | Office of the Assistant Secretary for Health | $500,000 | Forecast |
| Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required | Food and Drug Administration | $900,000 | Forecast |
| Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required) | Food and Drug Administration | $2,000,000 | Forecast |
| Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional | Food and Drug Administration | $300,000 | Forecast |
| Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed | Food and Drug Administration | $300,000 | Forecast |
| FDA OMHHE Convener for Racial & Ethnic minority Acceleration Consortium for Health Equity (REACH) | Food and Drug Administration | Not specified | Forecast |
| Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed | Food and Drug Administration | $1,000,000 | Forecast |
| Studies Addressing Rare Neurodegenerative Diseases including ALS | Food and Drug Administration | Not specified | Forecast |
| Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed | Food and Drug Administration | $250,000 | Forecast |
| Cooperative Agreement to Support Effective Dissemination of Clinical Practice Guidelines | Food and Drug Administration | $1,000,000 | Forecast |
| Collaborations to Enhance Drug Development and Regulatory Science | Food and Drug Administration | $5,000,000 | Forecast |
| GPD Grant Forecast | Homeless Providers Grant and Per Diem Program | Not specified | Forecast |
| Rapid Response Team (RRT) Cooperative Agreement | Food and Drug Administration | Not specified | Forecast |
| Mechanisms Underlying Olfactory Dysfunction in Aging and Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias | National Institutes of Health | Not specified | Forecast |
| Understanding Cerebellar Contributions to Cognitive and Affective Functions in Aging and Alzheimer's Disease/Alzheimer's Disease-Related Dementias | National Institutes of Health | Not specified | Forecast |
| Illuminating AD/ADRD Genome to Enable Precision Genomic Medicine | National Institutes of Health | Not specified | Forecast |
| Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Novel Approaches to Advance Precision Aging and Cognitive Health | National Institutes of Health | Not specified | Forecast |
| Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection – Network Sites and Coordinating Center (U01- CT Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimer’s and Related Dementias Disease Risk | National Institutes of Health | Not specified | Forecast |
| Translational Center for Accelerating the Use of Digital Health Technologies Data in AD/ADRD Research | National Institutes of Health | Not specified | Forecast |
| High-Priority Research in Tobacco Regulatory Science (Clinical Trial Optional) | National Institutes of Health | $500,000 | Forecast |
| George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Limited Competition: Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium- Field Epidemiology Sites | National Institutes of Health | Not specified | Forecast |
| Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| HEAL Initiative: Program to Reveal and Evaluate Cells-to-gene Information that Specify Intricacies, Origins and the Nature of (PRECISION) Human Pain Network | National Institutes of Health | Not specified | Forecast |
| Improving Chronic Conditions Through Inexpensive Interventions | National Institutes of Health | Not specified | Forecast |
| Network of the National Library of Medicine Coordinating Center (U24 Clinical Trial Optional) | National Institutes of Health | $1,500,000 | Forecast |
| Network of the National Library of Medicine Training Center (U24 Clinical Trial Not Allowed) | National Institutes of Health | $750,000 | Forecast |
| Network of the National Library of Medicine Regional Medical Libraries (UG4 Clinical Trial Not Allowed) | National Institutes of Health | $600,000 | Forecast |
| Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Dental Primary Care Practice-Based Research Network: Administrative and Resource Center | National Institutes of Health | Not specified | Forecast |
| Dental Primary Care Practice-Based Research Network: Coordinating Center | National Institutes of Health | Not specified | Forecast |
| HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) | National Institutes of Health | Not specified | Forecast |
| Dental Primary Care Practice-Based Research Network: Clinical Trial or Observational Study Planning and Implementation Cooperative Agreement | National Institutes of Health | Not specified | Forecast |
| Establishing Pediatric CNS Pharmacodynamic Measures as Tools to Enable Psychiatric Indications in Adolescents | National Institutes of Health | Not specified | Forecast |
| Maternal and Pediatric Precision in Therapeutics (MPRINT) Knowledge and Research Coordination Center | National Institutes of Health | Not specified | Forecast |
| Maternal Medications and Human Milk Research Center (M2HMRC) | National Institutes of Health | Not specified | Forecast |
| Data Sharing for Demographic Research Infrastructure Program | National Institutes of Health | $600,000 | Forecast |
| NEI Collaborative Clinical Vision Research (UG1 - Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| HEAL Initiative: Optimization of Therapeutic Medical Devices through Team Science Mechanistic Research (RM1) | National Institutes of Health | Not specified | Forecast |
| Novel approaches to support therapeutic development in ultra-rare cancers | Food and Drug Administration | Not specified | Forecast |
| Pediatric and Reproductive Environmental Health Scholars (PREHS) Program | National Institutes of Health | Not specified | Forecast |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| The NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC) | National Institutes of Health | Not specified | Forecast |
| The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Data Coordinating Center | National Institutes of Health | Not specified | Forecast |
| The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genomic Research Centers | National Institutes of Health | Not specified | Forecast |
| The NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC) | National Institutes of Health | Not specified | Forecast |
| Toolkits for Dissemination of Genomic Technologies | National Institutes of Health | $50,000 | Forecast |
| Centers of Excellence in Genomic Science (CEGS) | National Institutes of Health | Not specified | Forecast |
| Autism Centers of Excellence R01 | National Institutes of Health | Not specified | Forecast |
| Autism Centers of Excellence P50 | National Institutes of Health | Not specified | Forecast |
| Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed) | National Institutes of Health | Not specified | Forecast |
| Research Council of Finland (RCF) – National Institutes of Health (NIH) Partnership Program | National Institutes of Health | Not specified | Forecast |
| Investigate Novel Therapeutic Interventions and Testing Strategies for Neurological Disorders Including to Treat, Modify and Prevent the Development of Epilepsy (U24 Clinical Trial Not Allowed) | National Institutes of Health | $4,000,000 | Forecast |
| Interdisciplinary Research Networks to Advance Biomedical Research on Resilience and Health Optimization | National Institutes of Health | Not specified | Forecast |
| Intramural - Extramural Collaboration for Advanced 3-D Tissue Models for Drug Screening (Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Renewal of NIA Research Centers Collaborative Network (RCCN) | National Institutes of Health | Not specified | Forecast |
| Single Source for Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Data Coordinating Center (DCC) | National Institutes of Health | Not specified | Forecast |
| Building Sustainable Software Tools for Open Science (R03 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Single Source: Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium- Renal and Environmental Science Core (U01-Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| ORACLE 3C: Chronic Conditions, Coinfections, and Comorbidities in HIV | National Institutes of Health | Not specified | Forecast |
| Genomic Community Resources (U24 Clinical Trials Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD) | National Institutes of Health | Not specified | Forecast |
| Exposomic Contributions to ADRD Pathology and Resilience | National Institutes of Health | Not specified | Forecast |
| Functional Target Validation for Alzheimer's Disease-Related Dementias | National Institutes of Health | Not specified | Forecast |
| Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) | National Institutes of Health | Not specified | Forecast |
| Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Global Brain and Nervous System Disorders Research Across the Lifespan - Exploratory Grants | National Institutes of Health | Not specified | Forecast |
| BRAIN Initiative: Data Archives for the BRAIN Initiative | National Institutes of Health | Not specified | Forecast |
| Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials | National Institutes of Health | Not specified | Forecast |
| National Resource Network for the Study of Human Auditory and Vestibular Disorders | National Institutes of Health | $450,000 | Forecast |
| Coordinating Center for National Resource Network for the Study of Human Auditory and Vestibular Disorders | National Institutes of Health | $100,000 | Forecast |
| Resource-Related Research Projects Cooperative Agreements in Aging and/or Alzheimer's Disease (AD) and Alzheimer's Disease-Related Dementias (ADRD) Research | National Institutes of Health | Not specified | Forecast |
| Restoring Joint Health and Function to Reduce Pain (RE-JOIN) 2.0 | National Institutes of Health | Not specified | Forecast |
| Research Project Cooperative Agreements in Aging and/or Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) Research | National Institutes of Health | Not specified | Forecast |
| Specialized Center Cooperative Agreements in Aging and/or Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Research | National Institutes of Health | Not specified | Forecast |
| BRAIN Initiative: Brain-Behavior Quantification and Synchronization – Transformative Research on Behavior at the Organismal Level | National Institutes of Health | Not specified | Forecast |
| Controlled Clinical Trials on Long-Term Effects of Nutritional Interventions on the Progression of Risk Factors for Age-Related Chronic Conditions Over the Life Span and Their Age of Onset | National Institutes of Health | Not specified | Forecast |
| Rigor and Reproducibility for Biomarkers in Type 1 Diabetes Clinical Research | National Institutes of Health | Not specified | Forecast |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Therapeutic Agent Characterization and Preclinical Efficacy Studies | National Institutes of Health | Not specified | Forecast |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Therapeutic Agent Identification | National Institutes of Health | Not specified | Forecast |
| Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Impact of Immunotherapies on CNS Outcomes in People with HIV: Potential Benefits, Challenges and Risks | National Institutes of Health | Not specified | Forecast |
| Clinical Trials and Ancillary Studies Conducted within NIH-Funded Clinical Trial Research Networks (UG3/UH3 - Clinical Trial Required) | National Institutes of Health | Not specified | Forecast |
| NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Intervention Research to Improve Native American Health | National Institutes of Health | Not specified | Forecast |
| NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Family Unification Program (FUP) Multi-Year NOFO | Department of Housing and Urban Development | $1,700,000 | Forecast |
| Research Resource for a National Swine Resource and Research Center (U42 Clinical Trial Not Allowed) | National Institutes of Health | $1,008,943 | Forecast |
| NIH Blueprint Initiative: Tools for Germline Gene Editing in the Nervous System | National Institutes of Health | $1,200,000 | Forecast |
| NIDA Core "Center of Transformative Science" Grant Program | National Institutes of Health | Not specified | Forecast |
| Advancing Screening, Diagnosis, and Referral for Late Talking Children | National Institutes of Health | $500,000 | Forecast |
| National Biomedical Research Centers (P50 Clinical Trial Optional) | National Institutes of Health | $11,405,967 | Forecast |
| Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (R24 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| NIDCD Research Fellowship for Audiologists | National Institutes of Health | Not specified | Forecast |
| Limited Competition: The NHGRI Analysis, Visualization, and Informatics Lab-space (AnVIL) (U54 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| ancient DNA for Modern Genomics (aDMG) Research Projects (U01 Clinical Trials Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required) | National Institutes of Health | Not specified | Forecast |
| Research on the Ethical, Legal and Social Implications (ELSI) of Genomics | National Institutes of Health | Not specified | Forecast |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | National Institutes of Health | Not specified | Forecast |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | National Institutes of Health | Not specified | Forecast |
| HIV/AIDS Clinical Trials Network Laboratory Centers | National Institutes of Health | Not specified | Forecast |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | National Institutes of Health | Not specified | Forecast |
| Cooperative Program for Modeling Clinical Transplantation | National Institutes of Health | Not specified | Forecast |
| Feasibility Studies to Inform the Design of Future Clinical Trials | National Institutes of Health | Not specified | Forecast |
| NIH Pragmatic Trials Conducted in Health Care Systems | National Institutes of Health | Not specified | Forecast |
| Establishing a Research Network to Guide Foundational Research on Human Consciousness | National Institutes of Health | Not specified | Forecast |
| Claude D. Pepper Older Americans Independence Centers | National Institutes of Health | Not specified | Forecast |
| Resident Opportunity and Self-Sufficiency Service Coordinator (ROSS-SC) Program – Fiscal Year 2026 | Department of Housing and Urban Development | $816,750 | Forecast |
| NIH Specialized Center Grant (Parent P50) | National Institutes of Health | Not specified | Forecast |
| National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional) | National Institutes of Health | Not specified | Forecast |
| Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases | National Institutes of Health | $600,000 | Forecast |
| NIAMS Clinical Trial Implementation Cooperative Agreement | National Institutes of Health | Not specified | Forecast |
| A Holistic Approach to Study Non-Addictive Natural Products for Pain Management | National Institutes of Health | Not specified | Forecast |
| Centers of Excellence in Healthcare Quality and Safety | Centers for Disease Control - NCEZID | $22,000,000 | Forecast |
| The NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS) | National Institutes of Health | Not specified | Forecast |
| Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV/AIDS Research (U42 Clinical Trial Not Allowed) | National Institutes of Health | $2,725,311 | Forecast |
| NIOSH Robotics and Intelligent Mining Technology and Workplace Safety Research (U60) | Centers for Disease Control and Prevention - ERA | $2,000,000 | Forecast |
| NIOSH Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed) | Centers for Disease Control and Prevention - ERA | $20,000 | Forecast |
| Maternal-Child Surveillance and Partnerships for Action, Results, and Knowledge | Centers for Disease Control - NCBDDD | Not specified | Forecast |
| Pilot Testing, Implementation, and Evaluation of the Cervical, Breast and Colorectal Cancer Clinical Decision Support Tools | Centers for Disease Control and Prevention - ERA | Not specified | Forecast |
| Strengthening Services to Prevent the Infectious Disease Consequences of Drug Use | Centers for Disease Control - NCHHSTP | Not specified | Forecast |
| DHQP Global NOFO | Centers for Disease Control - NCEZID | Not specified | Forecast |
| Transformative Technologies for Experimental and Computational RNome Characterization and Functional Analysis | National Institutes of Health | $500,000 | Forecast |
| RNomics Molecular Standards | National Institutes of Health | Not specified | Forecast |
| RNomics Outreach and Coordination (ROC) Center | National Institutes of Health | Not specified | Forecast |
| Rural Residency Planning and Development Program | Health Resources and Services Administration | $750,000 | Forecast |
| Rural Health Value Program | Health Resources and Services Administration | $650,000 | Forecast |
| Partnership with Common Fund Data Ecosystem Resources | National Institutes of Health | $1,200,000 | Forecast |
| Holistic and Evidence-Informed Wellness for STI Prevention | Centers for Disease Control - NCHHSTP | Not specified | Forecast |
| Women's Initiative for Screening and Health (WISH) | Health Resources and Services Administration | $1,000,000 | Forecast |
| Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) Infrastructure – Clinical Coordinating Center (CCC) and Data Coordinating Center (DCC) | National Institutes of Health | Not specified | Forecast |
| Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) Infrastructure – Clinical Enrollment Hubs | National Institutes of Health | Not specified | Forecast |
| Mentored Career Transition Award (KT1/R00) | National Institutes of Health | Not specified | Forecast |
| Mentored Clinician Research Scientist Career Development Award (KC1) | National Institutes of Health | Not specified | Forecast |
| Mentored Research Scientist Career Development Award (KR1) | National Institutes of Health | Not specified | Forecast |
| Rural Health Network Development Program | Health Resources and Services Administration | $500,000 | Forecast |
| Rural Maternity and Obstetrics Management Strategies Program | Health Resources and Services Administration | $1,000,000 | Forecast |
| Established Clinician Investigator Award to Support Mentoring (KS1) | National Institutes of Health | Not specified | Forecast |
| Surveillance and Case Control Study of Stillbirth and Birth Defects (SUCCSSBD) | Centers for Disease Control - NCBDDD | Not specified | Forecast |
| Capacity Building for Global, Regional, and National Immunization Programs | Centers for Disease Control-GHC | $120,000,000 | Forecast |
| Promoting Population Health through Increased Capacity in Alcohol Epidemiology & the Prevention of Excessive Alcohol Use | Centers for Disease Control - NCCDPHP | Not specified | Forecast |
| NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Bridge2AI Network for AI Health Science | National Institutes of Health | $7,000,000 | Forecast |
| Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development | National Institutes of Health | Not specified | Forecast |
| Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) | Centers for Disease Control and Prevention - ERA | $500,000 | Forecast |
| NIOSH Miner Safety and Health Training Program - Western United States – U60 | Centers for Disease Control and Prevention - ERA | $250,000 | Forecast |
| Clinical and Translational Science Award | National Institutes of Health | Not specified | Forecast |
| Improving Linkage to Care for People with Opioid Use Disorder (U01) | Centers for Disease Control and Prevention - ERA | $550,000 | Forecast |
| The Next Generation of the Clinical and Translational Science Awards Program Trial Innovation Network | National Institutes of Health | Not specified | Forecast |
| Undiagnosed Diseases Network (UDN) Clinical Networks of Diagnostic Excellence | National Institutes of Health | Not specified | Forecast |
| Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure – Clinical Research Sites (U24 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| R3PEATS Grassroots Rigor Projects: Individual Metascience and Individual Laboratory Capacity-Building (RP1) | National Institutes of Health | Not specified | Forecast |
| R3PEATS Multi-Team Triangulation: Collaborative Cross-Method Approaches to Scientific Discovery (RM1) | National Institutes of Health | Not specified | Forecast |
| R3PEATS Rigor Scholar Cohort Awards (K12) | National Institutes of Health | Not specified | Forecast |
| Undiagnosed Diseases Network (UDN) Clinical and Data Coordinating Center | National Institutes of Health | Not specified | Forecast |
| Undiagnosed Diseases Network (UDN) Diagnostic Research Innovation Center | National Institutes of Health | Not specified | Forecast |
| NIDA Avenir Program: Fundamental Mechanistic Research in Addiction Science | National Institutes of Health | $375,000 | Forecast |
| Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure – Clinical Coordinating Center (CCC) & Data Coordinating Center (DCC) | National Institutes of Health | Not specified | Forecast |
| NIH Stroke Clinical Trials Network (StrokeNet) Infrastructure – Regional Coordinating Stroke Centers (RCCs) | National Institutes of Health | Not specified | Forecast |
| BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System | National Institutes of Health | Not specified | Forecast |
| NIH Stroke Clinical Trials Network (StrokeNet) Infrastructure – National Coordinating Center (NCC) and National Data Management Center (NDMC) | National Institutes of Health | Not specified | Forecast |
| Homeless Veterans’ Reintegration Program (HVRP), Incarcerated Veterans’ Transition Program (IVTP), and the Homeless Women Veterans' and Homeless Veterans' with Children Reintegration Grant Program (HWVHVWC) (referred to collectively as HVRP) | Veterans Employment and Training Service | $500,000 | Forecast |
| Limited Competition: BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships | National Institutes of Health | Not specified | Forecast |
| Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Mechanistic Toxicology of METALS: Metal Exposure, Transport, Action, Localization, and Susceptibility (RP1 Clinical Trial Not Allowed) | National Institutes of Health | $500,000 | Forecast |
| Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (R24 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Head Start/Early Head Grants in Multiple States | Administration for Children and Families - OHS | $79,657,340 | Forecast |
| Early Head Start Expansion and Early Head Start - Child Care Partnership Grants in Multiple States | Administration for Children and Families - OHS | $4,964,843 | Forecast |
| Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) | National Institutes of Health | Not specified | Forecast |
| Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed) | National Institutes of Health | $500,000 | Forecast |
| Technology Development Program | National Institutes of Health | Not specified | Forecast |
| Research to Improve Rigor, Replicability, and Reproducibility in Biomedical and Behavioral Sciences | National Institutes of Health | Not specified | Forecast |
| State Biomonitoring Cooperative Agreement | Centers for Disease Control - NCEH | $900,000 | Forecast |
| Implementation Research on Multi-component Community-Clinical Linkage Approaches for Diabetes Prevention and Management | Centers for Disease Control and Prevention - ERA | $725,000 | Forecast |
| Fiscal Year (FY) 2027 Service Area Competition (SAC) | Health Resources and Services Administration | $15,335,500 | Forecast |
| Fiscal Year (FY) 2027 Service Area Competition (SAC) | Health Resources and Services Administration | $19,182,000 | Forecast |
| Fiscal Year (FY) Service Area Competition (SAC) | Health Resources and Services Administration | $22,024,900 | Forecast |
| Fiscal Year (FY) 2027 Service Area Competition (SAC) | Health Resources and Services Administration | $1,500,231 | Forecast |
| Immune Drivers of Autoimmune Disease | National Institutes of Health | Not specified | Forecast |
| Collaborative Centers in Children’s Environmental Health Research and Translation (P2C Clinical Trial Optional) | National Institutes of Health | $750,000 | Forecast |
| NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) | National Institutes of Health | $80,000 | Forecast |
| Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Partnerships for Advancing Development of Diagnostics for Infectious Diseases | National Institutes of Health | Not specified | Forecast |
| The Role of the Innate Immune System in the Pathogenesis of Type 1 Diabetes | National Institutes of Health | Not specified | Forecast |
| LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE) | National Institutes of Health | Not specified | Forecast |
| National Breastfeeding Support, Implementation, and Hospital Quality Improvement Initiative | Centers for Disease Control - NCCDPHP | Not specified | Forecast |
| Promoting Cancer Surveillance Workforce, Education, and Data Use | Centers for Disease Control - NCCDPHP | Not specified | Forecast |
| Clinical Data, Safety and Statistical Centers (CDSSC) | National Institutes of Health | Not specified | Forecast |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | National Institutes of Health | Not specified | Forecast |
| Improved Drug Susceptibility Testing (DST) for Mycobacteria | National Institutes of Health | Not specified | Forecast |
| Collaborative Network for Clinical Research on Immune Tolerance | National Institutes of Health | Not specified | Forecast |
| AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) | National Institutes of Health | $1,500,000 | Forecast |
| Translational Centers Using Microphysiologic Systems for Infectious Diseases | National Institutes of Health | Not specified | Forecast |
| Asthma and Allergic Diseases Cooperative Research Centers | National Institutes of Health | Not specified | Forecast |
| Childhood Asthma in Urban Settings Clinical Research Network | National Institutes of Health | Not specified | Forecast |
| Clinical Trials in Organ Transplantation in Children and Adults | National Institutes of Health | Not specified | Forecast |
| Translational Transplantation Tolerance Cooperative Study Group | National Institutes of Health | Not specified | Forecast |
| BRAIN Initiative: Development and Validation of Novel Tools and New Approaches for Neuroscience Research | National Institutes of Health | Not specified | Forecast |
| Health and Extreme Weather Solutions-Focused Research Hubs (U54 - Clinical Trial Optional) | National Institutes of Health | $2,000,000 | Forecast |
| Health and Extreme Weather Research Coordination and Data Center (U2C - Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and Providers | Centers for Disease Control - NCHHSTP | Not specified | Forecast |
| Preventing Suicide and Interpersonal Violence Among Youth and Young Adults | Centers for Disease Control and Prevention - ERA | $500,000 | Forecast |
| Rigorously Evaluating Approaches to Prevent Child Sexual Abuse and Problematic Sexual Behavior among Youth | Centers for Disease Control and Prevention - ERA | $400,000 | Forecast |
| New Investigator Grants to Conduct Research to Prevent Interpersonal Violence and Suicide Among Children and Adolescents (K01) | Centers for Disease Control and Prevention - ERA | $150,000 | Forecast |
| Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | National Institutes of Health | $300,000 | Forecast |
| Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) | National Institutes of Health | $150,000 | Forecast |
| Digital Health Technology and Reciprocal Innovation to Improve Clinical and Public Health Outcomes | National Institutes of Health | Not specified | Forecast |
| KUH P30 Resource Core Center (P30 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| KUH U24 Center Coordinating Hub (U24 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| CDC National Centers of Excellence in Youth Violence Prevention (YVPCs): Rigorous Evaluation of Prevention Approaches to Prevent and Reduce Youth Violence | Centers for Disease Control and Prevention - ERA | $1,200,000 | Forecast |
| NIOSH Centers for Agriculture, Forestry, and Fishing Safety and Health (U54) | Centers for Disease Control and Prevention - ERA | $2,200,000 | Forecast |
| Elucidation and Validation of the role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain Barrier | National Institutes of Health | Not specified | Forecast |
| Opportunities for Collaborative Research with the NIH Intramural Research Program (U01 Clinical Trial Optional) | National Institutes of Health | $500,000 | Forecast |
| Occupational Safety and Health Research (R01) | Centers for Disease Control and Prevention - ERA | $680,000 | Forecast |
| Telehealth Nutrition Services Network Grant Program | Health Resources and Services Administration | $300,000 | Forecast |
| Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24) | Centers for Disease Control and Prevention - ERA | $1,100,000 | Forecast |
| NIOSH Support for Conferences and Scientific Meetings (U13 Clinical Trial Not Allowed) | Centers for Disease Control and Prevention - ERA | $30,000 | Forecast |
| World Trade Center Youth Research Coordinating Center (U54) | Centers for Disease Control and Prevention - ERA | $10,000,000 | Forecast |
| Family-to-Family Health Information Centers (F2F HIC) | Health Resources and Services Administration | $96,750 | Forecast |
| Core State Injury Prevention Program (Core SIPP) | Centers for Disease Control - NCIPC | Not specified | Forecast |
| NIOSH Small Research Grant Program (R03) | Centers for Disease Control and Prevention - ERA | $100,000 | Forecast |
| NIOSH National Center of Excellence for the Prevention of Childhood Agricultural Injury (U54) | Centers for Disease Control and Prevention - ERA | $1,600,000 | Forecast |
| Expanded Surveillance for Pediatric Infectious Diseases | Centers for Disease Control and Prevention - ERA | $1,140,000 | Forecast |
| NIOSH Exploratory/Developmental Grant Program (R21) | Centers for Disease Control and Prevention - ERA | $300,000 | Forecast |
| Early Detection, Response, and Control of Global Rabies Outbreaks and Associated Threats to America's Dog-Rabies Free Status | Centers for Disease Control and Prevention - ERA | $400,000 | Forecast |
| Investigator-Focused Award (Parent R35) | National Institutes of Health | Not specified | Forecast |
| Demonstration Projects for Whole-Person Health Models for Women Living with HIV in the South | Centers for Disease Control - NCHHSTP | Not specified | Forecast |
| RNomics Technology Enhancement Centers | National Institutes of Health | $2,000,000 | Forecast |
| Research Grants to Rigorously Evaluate Innovative and Promising Approaches to Prevent Firearm-Related Violence and Injuries | Centers for Disease Control and Prevention - ERA | $650,000 | Forecast |
| Tobacco Centers of Regulatory Science (TCORS) (Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| World Trade Center Health Program Mentored Research Scientist Career Development Award (K01) | Centers for Disease Control and Prevention - ERA | $189,000 | Forecast |
| Microplastics Research and Resource Coordination Center (U24 - Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) | National Institutes of Health | Not specified | Forecast |
| NIDDK Multi-Purpose Resource-Related, Multi-Component Research Services Centers Cooperative Agreement (U2C - Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | National Institutes of Health | $600,000 | Forecast |
| INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Comprehensive Suicide Prevention Program for States | Centers for Disease Control - NCIPC | $1,200,000 | Forecast |
| Statewide Perinatal Quality Collaboratives: Improving Perinatal Care and Outcomes | Centers for Disease Control - NCCDPHP | Not specified | Forecast |
| Improving Protection against Influenza and Other Respiratory Pathogens: the US Flu VE Network | Centers for Disease Control and Prevention - ERA | $3,550,000 | Forecast |
| NIOSH Centers of Excellence for Total Worker Health® (U19) | Centers for Disease Control and Prevention - ERA | $1,400,000 | Forecast |
| The National Network of STI Prevention Training Centers (NNPTC) | Centers for Disease Control - NCHHSTP | $1,000,000 | Forecast |
| Rural Communities Opioid Response Program - Evaluation | Health Resources and Services Administration | $5,000,000 | Forecast |
| Rural Communities Opioid Response Program - Community Systems Development | Health Resources and Services Administration | $500,000 | Forecast |
| Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2 | National Institutes of Health | $1,000,000 | Forecast |
| Translational Research in Maternal and Pediatric Pharmacology and Therapeutics | National Institutes of Health | Not specified | Forecast |
| Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) | National Institutes of Health | $1,000,000 | Forecast |
| Rural Communities Opioid Response Program - Overdose Response | Health Resources and Services Administration | $300,000 | Forecast |
| Rural Communities Opioid Response Program - Child and Adolescent Behavioral Health | Health Resources and Services Administration | $1,000,000 | Forecast |
| Multimodal AI to Accelerate Precision Medicine for Type 1 Diabetes (U01- Clinical Trials Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Regional Excellence for Access to Comprehensive Care for Hemophilia Networks (REACH Networks) | Health Resources and Services Administration | $450,000 | Forecast |
| Small Instruments and Modern Equipment for Shared-use Biomedical Research Facilities and Resources (S15 Clinical Trial Not Allowed) | National Institutes of Health | $350,000 | Forecast |
| Innovative Research to Improve Native Hawaiian and Pacific Islander (NHPI) Health Outcomes (R34 - Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Fetal, Infant, and Child Death Review Program | Health Resources and Services Administration | $5,149,000 | Forecast |
| Supporting Community Application of Life-Saving Evidence to Prevent Injury and Violence (SCALE) | Centers for Disease Control - NCIPC | Not specified | Forecast |
| NIOSH Mentored Research Scientist Development Award (K01) | Centers for Disease Control and Prevention - ERA | $100,000 | Forecast |
| Residential Services for Unaccompanied Alien Children | Administration for Children and Families - ORR | $5,600,000 | Forecast |
| NIH Director's Early Independence Award (DP5 Clinical Trial Optional) | National Institutes of Health | $350,000 | Forecast |
| NIH Director's Pioneer Award (DP1 Clinical Trial Optional) | National Institutes of Health | $700,000 | Forecast |
| NIH Director's New Innovator Award (DP2 Clinical Trial Optional) | National Institutes of Health | $475,000 | Forecast |
| NIH Director's Transformative Research Award (R01 Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Capacity Building for National Immunization Programs in the Eastern Mediterranean Region | Centers for Disease Control-GHC | Not specified | Forecast |
| Informing global polio eradication efforts through innovative modeling approaches | Centers for Disease Control-GHC | Not specified | Forecast |
| Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required) | National Institutes of Health | Not specified | Forecast |
| FY2026/2027 Community Compass Technical Assistance and Capacity Building Program Notice of Funding Opportunity | Department of Housing and Urban Development | $35,000,000 | Forecast |
| Social Impact Partnerships to Pay for Results Act Demonstration Projects | SIPPRA | Not specified | Forecast |
| HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional) | National Institutes of Health | Not specified | Forecast |
| Centers for Research on Neglected Infectious Diseases | National Institutes of Health | Not specified | Forecast |
| Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Program (U19 Clinical Trial Optional) | National Institutes of Health | Not specified | Forecast |
| Chronic Disease Education and Awareness | Centers for Disease Control - NCCDPHP | Not specified | Forecast |
| Fiscal Year 2027 Regional Nutrition Hubs | Health Resources and Services Administration | $1,000,000 | Forecast |
| Implementation and Evaluation of Databases to Examine AIDS | National Institutes of Health | Not specified | Forecast |
| Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed) | National Institutes of Health | $900,000 | Forecast |
| Coordinating Center for the Claude D. Pepper Older Americans Independence Centers (OAICs) | National Institutes of Health | Not specified | Forecast |
| Specialized Alcohol Research Centers (P50 Clinical trial Optional) | National Institutes of Health | Not specified | Forecast |
| Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) | National Institutes of Health | Not specified | Forecast |
| Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration (R33 Clinical Trial Required) | National Institutes of Health | Not specified | Forecast |